BX Swiss TOP 30 CHF

BX Swiss TOP 30 CHF handeln
1.371,11 PKT -4,74 PKT -0,34 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN SL0CLV

ISIN DE000SL0CLV3


Analysen zu BX Swiss TOP 30 CHF-Werten

Datum Rating Analyst
07.08.12 Givaudan neutral Credit Suisse Group
07.08.12 Givaudan underperform Cheuvreux SA
07.08.12 Richemont neutral J.P. Morgan Cazenove
06.08.12 ABB (Asea Brown Boveri) kaufen Hamburger Sparkasse AG (Haspa)
06.08.12 Givaudan sell Citigroup Corp.
06.08.12 Givaudan reduce Nomura
06.08.12 Givaudan outperform Exane-BNP Paribas SA
06.08.12 Givaudan equal-weight Morgan Stanley
06.08.12 Richemont neutral Sarasin Research
06.08.12 Logitech neutral Sarasin Research
06.08.12 Swiss Re hold Société Générale Group S.A. (SG)
06.08.12 Richemont buy Vontobel Research
06.08.12 Givaudan hold Vontobel Research
03.08.12 Holcim neutral J.P. Morgan Cazenove
03.08.12 Givaudan neutral Sarasin Research
03.08.12 Holcim hold ING
03.08.12 Givaudan hold Vontobel Research
03.08.12 UBS overweight J.P. Morgan Cazenove
02.08.12 Adecco SA outperform Exane-BNP Paribas SA
02.08.12 ABB (Asea Brown Boveri) halten Independent Research GmbH
02.08.12 UBS buy Nomura
02.08.12 UBS halten Independent Research GmbH
02.08.12 UBS outperform Keefe, Bruyette & Woods, Inc.
01.08.12 UBS buy Goldman Sachs Group Inc.
01.08.12 UBS neutral Goldman Sachs Group Inc.
01.08.12 UBS overweight J.P. Morgan Cazenove
01.08.12 UBS hold Société Générale Group S.A. (SG)
01.08.12 Holcim outperform Exane-BNP Paribas SA
01.08.12 UBS buy Nomura
01.08.12 UBS underperform Exane-BNP Paribas SA
31.07.12 UBS neutral Sarasin Research
31.07.12 UBS hold ING
31.07.12 Adecco SA buy Vontobel Research
31.07.12 UBS buy Vontobel Research
30.07.12 UBS overweight HSBC
30.07.12 Holcim buy UBS AG
30.07.12 Swisscom outperform Exane-BNP Paribas SA
30.07.12 ABB (Asea Brown Boveri) neutral Exane-BNP Paribas SA
30.07.12 Novartis hold Vontobel Research
27.07.12 Logitech outperform Exane-BNP Paribas SA